RedHill Biopharma (RDHL) Leases (2016 - 2025)
Historic Leases for RedHill Biopharma (RDHL) over the last 7 years, with Q2 2025 value amounting to $163000.0.
- RedHill Biopharma's Leases fell 6524.52% to $163000.0 in Q2 2025 from the same period last year, while for Jun 2025 it was $163000.0, marking a year-over-year decrease of 6524.52%. This contributed to the annual value of $302000.0 for FY2024, which is 6946.41% down from last year.
- According to the latest figures from Q2 2025, RedHill Biopharma's Leases is $163000.0, which was down 6524.52% from $302000.0 recorded in Q4 2024.
- In the past 5 years, RedHill Biopharma's Leases registered a high of $7.7 million during Q1 2022, and its lowest value of $163000.0 during Q2 2025.
- Its 5-year average for Leases is $3.9 million, with a median of $4.2 million in 2021.
- Per our database at Business Quant, RedHill Biopharma's Leases skyrocketed by 8329.22% in 2022 and then crashed by 8522.12% in 2023.
- Quarter analysis of 5 years shows RedHill Biopharma's Leases stood at $3.7 million in 2021, then soared by 83.29% to $6.7 million in 2022, then tumbled by 85.22% to $989000.0 in 2023, then tumbled by 69.46% to $302000.0 in 2024, then tumbled by 46.03% to $163000.0 in 2025.
- Its last three reported values are $163000.0 in Q2 2025, $302000.0 for Q4 2024, and $469000.0 during Q2 2024.